Targeting microbial metabolites to treat autism

Nat Med. 2022 Mar;28(3):448-450. doi: 10.1038/s41591-022-01711-8.

Authors

Rochellys Diaz Heijtz^{1

2}, Pierre Gressens^{3

4}, Jonathan R Swann^{3

5}

Affiliations

¹ Department of Neuroscience, Karolinska Institutet, Biomedicum, Stockholm, Sweden. rochellys.heijtz@ki.se.
² University of Rouen Normandy, INSERM U1239, Rouen, France. rochellys.heijtz@ki.se.
³ Department of Neuroscience, Karolinska Institutet, Biomedicum, Stockholm, Sweden.
⁴ Université de Paris, NeuroDiderot, Inserm, Paris, France.
⁵ School of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.

PMID: 35165452
DOI: 10.1038/s41591-022-01711-8

No abstract available

Publication types

Comment

MeSH terms

Animals
Anxiety
Autism Spectrum Disorder* / therapy
Autistic Disorder*
Brain / metabolism
Gastrointestinal Microbiome*
Mice

Grants and funding

MR/N006321/1/MRC_/Medical Research Council/United Kingdom